Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:20 PM
Ignite Modification Date:
2025-12-24 @ 10:20 PM
NCT ID:
NCT01297335
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of Hypertension
* Stable systolic blood pressure \>140 mmHg and \< 190 mmHg
* On 3 or more antihypertensive medications
* On a diuretic
* Patients must be able to understand the risks
Exclusion Criteria:
* Allergy to clonidine
* Presently on clonidine orally or transdermally
* Known or suspected correctable causes of secondary hypertension
* Breast Feeding or Pregnant women
* Unstable Ischemic Heart Disease
* Unstable Angina
* Intracoronary Stent Placement
* Coronary bypass within last 6 months
* Myocardial Infarction within last 6 months
* Congestive Failure
* Cardiac Arrhythmias
* Known Cerebral Vascular Disease
* Renal Disease
* Evidence of Injection Site Infection
* Known Bleeding Disorders
* Hepatic Insufficiency
* Renal Insufficiency
* Participation in an investigational drug study within 30 day of enrollment
* Prohibited Medications:
* Clonidine
* Yohimbine
* Tricyclic Antidepressants
* Mirtazapine
* Digitalis
* Reserpine
* Guanethidine
* Non-Steroidal Anti-inflammatory Medication
* Alcohol or Barbiturates within 48 hours of study procedure
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
30 Years
Maximum Age:
75 Years
Study:
NCT01297335
Study Brief:
Protocol Section:
NCT01297335